Author of the publication

Levetiracetam as monotherapy or add-on to valproate in the treatment of acute mania-a randomized open-label study

, , , , and . Psychopharmacology, 198 (2): 297–299 (2008)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML), , , , , , , , and . Leukemia, 16 (1): 22–29 (2002)A novel view on stem cell development: analysing the shape of cellular genealogies, , , and . Cell proliferation, 42 (2): 248–263 (2009)Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks, and . Bone marrow transplantation, (1996)Serum cytokine levels correlate with clinical parameters in Hodgkin's disease, , , , and . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (5): 477–482 (1995)Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , and . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1996)Regression with bounded outcome score: evaluation of power by bootstrap and simulation in a chronic myelogenous leukaemia clinical trial, , and . Statistics in medicine, 17 (17): 1909–1922 (1998)Detecting Trichinella infections using inverse microscopy and an improved larval counting technique, , , , , , and . Journal of helminthology, (2013)Development and implementation of an analysis tool for array-based comparative genomic hybridization, , , , , , and . Methods of information in medicine, 46 (5): 608–613 (2007)A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease, and . The New England journal of medicine, 339 (21): 1506–1514 (1998)Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF, , , , , , , , , and 3 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 12 (4): 471–477 (2001)